StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $37 at Raymond James
April 30, 2024 12:17 PM
Raymond James analyst Danielle Brill raised the price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) to $37.00 (from $34.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Form 10-Q Harmony Biosciences Hold For: Mar 31
April 30, 2024 8:01 AM
Form 8-K Harmony Biosciences Hold For: Apr 30
April 30, 2024 7:46 AM
Harmony Biosciences (HRMY) Tops Q1 EPS by 25c
April 30, 2024 7:14 AM
Harmony Biosciences (HRMY) Acquires Epygenix Therapeutics, Inc.
April 30, 2024 7:08 AM
Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wak
April 30, 2024 7:05 AM
Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets
April 30, 2024 7:00 AM